Patents by Inventor Pam Cohen

Pam Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200222462
    Abstract: The present disclosure relates generally to methods treatment of hematological cancers, such as blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), or Myelodysplastic Syndrome (MDS), comprising a combination of decitabine and a CD123-targeted therapy. In particular, the disclosed methods involve pretreatment of a patient with decitabine prior to administration of a CD123-targeted therapy.
    Type: Application
    Filed: November 27, 2019
    Publication date: July 16, 2020
    Applicants: Mustang Bio, Inc., City of Hope
    Inventors: Pam Cohen, Sadik Kassim, Ekta Patel, Elizabeth Budde, Stephen J. Forman